期刊文献+

脑胶质瘤患者预后相关影响因素分析 被引量:15

Analysis of factors related to prognosis in patients with glioma
下载PDF
导出
摘要 目的探讨影响脑胶质瘤患者预后的相关因素,为临床更准确地判断胶质瘤患者预后提供参考。方法回顾性分析浙江省立同德医院神经外科同一医疗组81例资料齐全的脑胶质瘤患者的临床资料,利用Cox比例风险模型进行预后相关因素的判定,以P<0.05为统计学判定标准。结果 Cox比例风险模型分析提示:术前KPS评分、年龄、肿瘤病理分级、术后放疗、替莫唑胺使用疗程、Ki-67表达对胶质瘤患者的预后有影响。结论年龄、肿瘤级别、术前KPS评分、术后放疗、Ki-67表达水平是脑胶质瘤患者的预后影响因素。年龄越大、病理分级越高、Ki-67表达水平越高、术前KPS评分越低者预后越差。术后进行放疗以及足够疗程的替莫唑胺化疗将有助于改善胶质瘤患者的预后。 Objective To analyze the relationship between clinical factors and prognosis in brain glioma in order to provide the theoretical reference for prognosis and treatment for glioma patients. Methods The clinical data of 81 patients with brain glioma treated in our hospital from January 2002 to November 2011 were analyzed retrospectively. The prognosis was analyzed by Cox multivariate model. P 〈 0.05 indicated that the factor was related to the survival. Results Through Cox/s multivariate logistic regression analysis, 6 factors might be related to the prognosis of patients with glioma, including preoperative Karnosky Performance Scale ( KPS ) score, age, pathological grading, postoperative radiotherapy, the courses of treatment of temozolomide (TMZ) and the expression level of Ki-67. Conclusions Age,pathology grade,preoperative KPS score,postoperative radiotherapy and the expression level of Ki-67 are independent factors which might affect the prognostic of patients with glioma. The patients with older age,lower preoperative KPS, higher pathological grade and higher level of Ki-67 have poorer prognosis. Postoperative radiotherapy and enough adequate chemotherapy using TMZ will be helpful to improve the prognosis of glioma.
出处 《临床神经外科杂志》 CAS 2015年第6期410-414,共5页 Journal of Clinical Neurosurgery
关键词 胶质瘤 生存分析 预后 glioma survival analysis prognosis
  • 相关文献

参考文献3

二级参考文献10

  • 1Sathornsumetee S Rich JN.New treatment strategies for malignant gliomas[J].中国神经肿瘤杂志,2006,4(2):92-92. 被引量:5
  • 2Lisa M, DeAngelis MD. Brain Tumour [ J ]. N Engl J Med, 2001, 344:114. 被引量:1
  • 3Bergamaschi D,Samuels Y, 0 Nell NJ,et al. IASPP oncoprotein is a key inhibitor of p53 conserved from worm to human. Nat Genet, 2003,33:162. 被引量:1
  • 4Zhang X, Wang M,Zhou C, et al. The expression of IASPP in acute leukemias[ J]. Leuk Res ,2005,29 : 179. 被引量:1
  • 5Zhao J, Wu G, Bu F,et al. Epigenetic silence of ankyrin-repeat- containing, SH3-domain-containing, and proline-rich-region- containing protein 1 ( ASPP1 ) and ASPP2 genes promotes tumor growth in hepatitis B virus-positive hepatocellular carcinoma [ J ]. Hepatobiliary ,2010,51 : 142. 被引量:1
  • 6Bell HS, Ryan KM. IASPP inhibition:increased options in targeting the p53 family for cancer therapy [ J ]. Cancer Res,2008 ,68 :4959. 被引量:1
  • 7Lu B, Guo H, Zhao J,et al. Increased expression of iASPP, regulated by hepatitis B virus X protein-mediated NF-KB activation, in hepatocellular carcinoma. Gastroenterology [ J ]. 2010,12,139:2183. 被引量:1
  • 8Jiang L, Siu MK, Wong OG, et al. IASPP and chemoresistance in ovarian cancers: effects on paclitaxel-mediated mitotic catastrophe [ J ]. Clin Cancer Res, 20! 1,17:6924. 被引量:1
  • 9ZHU Yong-jian ZHU Xiang-dong WANG Sheng-hu SHEN Fang SHEN Hong LIU Wei-guo.A multivariate analysis of the prognostic factors of grade Ⅲ gliomas[J].Chinese Medical Journal,2008(12):1072-1075. 被引量:6
  • 10胡新华,张锐,马骏,陈永严,张岩松,邹元杰,章文斌,苗伟,刘宏毅.胶质瘤中P53、EGFR、Ki-67及MGMT的表达及临床意义[J].临床神经外科杂志,2011,8(4):187-189. 被引量:4

共引文献13

同被引文献146

引证文献15

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部